Tonix Pharmaceuticals Announces Issuance of Patent in China for the Composition and Formulation of TNX-102 SL
June 13, 2019 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing small...
Tonix Pharmaceuticals Presented Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology
May 30, 2019 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing small molecules...
Tonix Pharmaceuticals to Present at BIO 2019 International Convention
May 28, 2019 16:15 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer...
Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate TNX-1300 for Cocaine Intoxication
May 23, 2019 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Phase 2 Program Granted Breakthrough Therapy Designation by FDA Emergency Room Visits for Cocaine Abuse Total More than 500,000 Annually in U.S. NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) --...
Tonix Pharmaceuticals to Speak at the Second Chance Digital Impact Recipient Gala
May 22, 2019 16:19 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that Seth Lederman, M.D., President and Chief Executive Officer...
Tonix Pharmaceuticals Will Present Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology
May 21, 2019 16:15 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 21, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that it will be presenting pharmacokinetic analyses of TNX-102...
Tonix Pharmaceuticals Announces Director Stepping Down
May 17, 2019 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced that Donald W. Landry, M.D., Ph.D., is stepping down from the Company’s Board of...
Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
May 13, 2019 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company developing pharmaceutical products to...
Tonix Pharmaceuticals Announces New Board Member, Daniel Goodman, M.D., MBA
May 08, 2019 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) today announced the appointment of Daniel Goodman, M.D., MBA to its Board of Directors,...
Tonix Pharmaceuticals Announces Update on the Collaborative Research and Development Agreement (CRADA) with the U.S. Army Medical Materiel Development Activity (USAMMDA)
April 23, 2019 13:51 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), announced on April 18, 2019 that the Company received a notice of termination,...